Pharmacovigilance|Homeopathic pharmacy |1st bhms

  Pharmacovigilance

 Ethymology

The word Pharmacovigilance (PV) is a mixture of Greek word “Pharmacon” which means “medicinal substances” and 

the Latin word “Vigili” which means “to keep watch”.

Definition:

Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.

Adverse drug reaction (ADR) means the unintended and noxious reactions of administered drug and related items.

Pharmacovigilance Centre Hierarchy

Programme management unit: Ministry of Ayush 

 National Pharmacovigilance centre ( NPvCC): All India Institute of Ayurveda ,New Delhi

Intermediary Pharmacovigilance Centre ( IPvCC)

 1. NIA , Jaipur

 2. ITRA , Jamnagar 35

 3. NIUM , Bangalore 11

 4.NIS , Chennai 14

 5. NIH , Kolkata 13

Pharmacovigilance in India

 In India awareness about the ADR was first started in October 1983 by organizing a seminar under the auspices of India Pharmacovigilance society at Maulana Azad Medical College, New Delhi.

 In 1989 ICMR sponsored the first project on adverse drug reactions in India in the department of pharmacology Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh.

 The first conference on ADR was organized in January 1997 by the Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai.

 Ministry of AYUSH & Pharmacovigilance 

Under the Ministry of AYUSH, Govt. of India there are currently 63 Pharmacovigilance centers including Ayurveda-28, Siddha-14, Homoeopathy-11 and, Unani- 10. It has three tiers

NEED IN आयुष of Pharmacovigilance 

*Misconceptions about ASU&H drugs

* Adulterations and contaminations of ASU&H drugs 

*Malpractices:

*Globalization of AYUSH systems

*Increased incidence of Objectionable Advertisements

Pharmacovigilance & Homeopathy 

Homoeopathy is system of therapeutic, in which such a medicine is applied in a given disease condition which has the capacity to produce a similar disease condition in healthy human being. Law Of Simillars